Clinical thyroidology最新文献_第2页

2023 Changes to the Bethesda Classification for Thyroid Nodule Cytopathology 2023甲状腺结节细胞病理学Bethesda分类的变化

Clinical thyroidology Pub Date : 2023-10-01 DOI: 10.1089/ct.2023;35.416-419

Lindsay A. Bischoff

引用次数: 0

Concurrently Increased Free T4 and Incompletely Suppressed TSH Concentrations Are Mainly Related to Levothyroxine Use 同时增加游离T4和不完全抑制TSH浓度主要与左甲状腺素的使用有关

Clinical thyroidology Pub Date : 2023-10-01 DOI: 10.1089/ct.2023;35.402-404

Mitsuru Ito, Takashi Akamizu

{"title":"Concurrently Increased Free T4 and Incompletely Suppressed TSH Concentrations Are Mainly Related to Levothyroxine Use","authors":"Mitsuru Ito, Takashi Akamizu","doi":"10.1089/ct.2023;35.402-404","DOIUrl":"https://doi.org/10.1089/ct.2023;35.402-404","url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 10 HypothyroidismConcurrently Increased Free T4 and Incompletely Suppressed TSH Concentrations Are Mainly Related to Levothyroxine UseMitsuru Ito and Takashi AkamizuMitsuru ItoCenter for Excellence in Thyroid Care, Kuma Hospital, Kobe, JapanSearch for more papers by this author and Takashi AkamizuCenter for Excellence in Thyroid Care, Kuma Hospital, Kobe, JapanSearch for more papers by this authorPublished Online:5 Oct 2023https://doi.org/10.1089/ct.2023;35.402-404AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 10Oct 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Mitsuru Ito and Takashi Akamizu.Concurrently Increased Free T4 and Incompletely Suppressed TSH Concentrations Are Mainly Related to Levothyroxine Use.Clinical Thyroidology®.Oct 2023.402-404.http://doi.org/10.1089/ct.2023;35.402-404Published in Volume: 35 Issue 10: October 5, 2023PDF download","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134936734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Can Thyroidectomy Be Performed Safely Before a Euthyroid State Is Achieved? 在达到甲状腺正常状态之前，甲状腺切除术是否安全?

Clinical thyroidology Pub Date : 2023-10-01 DOI: 10.1089/ct.2023;35.409-412

Kharisa N. Rachmasari, Omar El Kawkgi

{"title":"Can Thyroidectomy Be Performed Safely Before a Euthyroid State Is Achieved?","authors":"Kharisa N. Rachmasari, Omar El Kawkgi","doi":"10.1089/ct.2023;35.409-412","DOIUrl":"https://doi.org/10.1089/ct.2023;35.409-412","url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 10 HyperthyroidismCan Thyroidectomy Be Performed Safely Before a Euthyroid State Is Achieved?Kharisa N. Rachmasari and Omar El KawkgiKharisa N. Rachmasari Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Mayo Clinic Rochester, Minnesota, U.S.A.Search for more papers by this author and Omar El Kawkgi Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Mayo Clinic Rochester, Minnesota, U.S.A. Department of Endocrinology, Mayo Clinic Health System, Eau Claire, Wisconsin, U.S.A.Search for more papers by this authorPublished Online:5 Oct 2023https://doi.org/10.1089/ct.2023;35.409-412AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 10Oct 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Kharisa N. Rachmasari and Omar El Kawkgi.Can Thyroidectomy Be Performed Safely Before a Euthyroid State Is Achieved?.Clinical Thyroidology®.Oct 2023.409-412.http://doi.org/10.1089/ct.2023;35.409-412Published in Volume: 35 Issue 10: October 5, 2023PDF download","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"126 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134978228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Use and Abuse of Thyroid Hormone 甲状腺激素的使用和滥用

Clinical thyroidology Pub Date : 2023-09-01 DOI: 10.1089/ct.2023;35.347-349

Victor J. Bernet, Anne R. Cappola

引用次数: 0

Real-World Use of Teprotumumab and Tocilizumab in Moderate-to-Severe Steroid-Resistant Thyroid Eye Disease Teprotumumab和Tocilizumab在中重度类固醇抵抗性甲状腺眼病中的实际应用

Clinical thyroidology Pub Date : 2023-09-01 DOI: 10.1089/ct.2023;35.364-367

Anupam Kotwal

引用次数: 0

Is There a Role for Examining Variant Allele Fraction in the Molecular Analysis of Thyroid Nodules? 变异等位基因在甲状腺结节分子分析中的作用?

Clinical thyroidology Pub Date : 2023-09-01 DOI: 10.1089/ct.2023;35.375-378

Paul Stewardson, Mayumi Endo

{"title":"Is There a Role for Examining Variant Allele Fraction in the Molecular Analysis of Thyroid Nodules?","authors":"Paul Stewardson, Mayumi Endo","doi":"10.1089/ct.2023;35.375-378","DOIUrl":"https://doi.org/10.1089/ct.2023;35.375-378","url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 9 Thyroid NodulesIs There a Role for Examining Variant Allele Fraction in the Molecular Analysis of Thyroid Nodules?Paul Stewardson and Mayumi EndoPaul Stewardson Department of Medical Science, Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.Search for more papers by this author and Mayumi Endo Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, U.S.A.Search for more papers by this authorPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.375-378AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Paul Stewardson and Mayumi Endo.Is There a Role for Examining Variant Allele Fraction in the Molecular Analysis of Thyroid Nodules?.Clinical Thyroidology®.Sep 2023.375-378.http://doi.org/10.1089/ct.2023;35.375-378Published in Volume: 35 Issue 9: September 13, 2023PDF download","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135298233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Oncologic Outcomes of Microwave Ablation for Papillary Thyroid Microcarcinomas with Capsular Invasion 微波消融治疗伴有囊膜浸润的甲状腺乳头状微癌的肿瘤预后

Clinical thyroidology Pub Date : 2023-09-01 DOI: 10.1089/ct.2023;35.379-380

Jie Liu

{"title":"Oncologic Outcomes of Microwave Ablation for Papillary Thyroid Microcarcinomas with Capsular Invasion","authors":"Jie Liu","doi":"10.1089/ct.2023;35.379-380","DOIUrl":"https://doi.org/10.1089/ct.2023;35.379-380","url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 9 Thyroid CancerOncologic Outcomes of Microwave Ablation for Papillary Thyroid Microcarcinomas with Capsular InvasionJie LiuJie LiuDepartment of Head and Neck Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of ChinaSearch for more papers by this authorPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.379-380AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article\"Oncologic Outcomes of Microwave Ablation for Papillary Thyroid Microcarcinomas with Capsular Invasion.\" Clinical Thyroidology®, 35(9), pp. 379–380FiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Jie Liu.Oncologic Outcomes of Microwave Ablation for Papillary Thyroid Microcarcinomas with Capsular Invasion.Clinical Thyroidology®.Sep 2023.379-380.http://doi.org/10.1089/ct.2023;35.379-380Published in Volume: 35 Issue 9: September 13, 2023PDF download","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135300061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Summary of State-of-the-Art Clinical Trials for Advanced Thyroid Cancers, Organized by the International Thyroid Oncology Group 由国际甲状腺肿瘤组织的晚期甲状腺癌最新临床试验综述

Clinical thyroidology Pub Date : 2023-09-01 DOI: 10.1089/ct.2023;35.350-354

Laura Boucai, Ashish Chintakuntlawar, David C. Shonka

{"title":"A Summary of State-of-the-Art Clinical Trials for Advanced Thyroid Cancers, Organized by the International Thyroid Oncology Group","authors":"Laura Boucai, Ashish Chintakuntlawar, David C. Shonka","doi":"10.1089/ct.2023;35.350-354","DOIUrl":"https://doi.org/10.1089/ct.2023;35.350-354","url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 9 EditorialFree AccessA Summary of State-of-the-Art Clinical Trials for Advanced Thyroid Cancers, Organized by the International Thyroid Oncology GroupLaura Boucai, Ashish Chintakuntlawar, David C. Shonka, Jr., and Members, ITOGLaura Boucai Division of Subspecialty Medicine, Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, U.S.A.Search for more papers by this author, Ashish Chintakuntlawar Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, U.S.A.Search for more papers by this author, David C. Shonka, Jr. Department of Otolaryngology—Head & Neck Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A.Search for more papers by this author, and Members, ITOGPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.350-354AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail This invited editorial provides a summary of the history and mission of the International Thyroid Oncology Group (ITOG), highlighting the continuing collaboration between Clinical Thyroidology and ITOG.The International Thyroid Oncology Group (ITOG, www.itog.org) is a not-for-profit organization founded in 2006 whose mission is to find a cure for the most challenging thyroid cancers. The group does this through the collaborative efforts of a multidisciplinary team of endocrinologists, surgeons, medical and radiation oncologists, basic scientists, and advocates by designing, coordinating, and prioritizing state-of-the-art clinical trials and correlative science studies.The organization grew out of a need for novel treatments in advanced thyroid cancer and was ultimately inspired by thyroid cancer patients such as Ms. Jean Vicks—a mother, a coach, and an avid outdoor enthusiast. After the initial meeting in 2003, the organization's inception was formalized at an inaugural meeting in Atlanta, Georgia, in 2006. The founding members included Drs. Robert Gagel, Samuel Wells, Jr., and Steven Sherman and Mr. Dwight Vicks. Since then, ITOG's membership has grown to include prominent scientists and leading clinicians in the field of thyroid cancer.Currently, ITOG's membership includes 132 leading physicians, scientists, and advocates from 16 countries: Australia, Brazil, Canada, China, France, Germany, Israel, Italy, the Netherlands, Saudi Arabia, Singapore, South Korea, Spain, Switzerland, the United Kingdom, and the United States. ITOG is organized into 12 committees and 7 task forces that work toward the common goal of finding new therapies for thyroid cancer, training the next generation of clinicians and scientists, and raising public awareness about the importance of thyroid cancer research.Through the tireless efforts and commitment of its members and advocates, ITOG has successfully completed seven clinical trials (Table 1). The ","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135298063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Preoperative Molecular Profiling of Bethesda V and Bethesda VI Thyroid Nodules May Inform Initial Surgical Approach and the Intensity of Postoperative Surveillance Bethesda V型和Bethesda VI型甲状腺结节的术前分子特征分析可以为初始手术入路和术后监测的强度提供信息

Clinical thyroidology Pub Date : 2023-09-01 DOI: 10.1089/ct.2023;35.371-374

Jessica Bindra, Matti L. Gild, Venessa Tsang

{"title":"Preoperative Molecular Profiling of Bethesda V and Bethesda VI Thyroid Nodules May Inform Initial Surgical Approach and the Intensity of Postoperative Surveillance","authors":"Jessica Bindra, Matti L. Gild, Venessa Tsang","doi":"10.1089/ct.2023;35.371-374","DOIUrl":"https://doi.org/10.1089/ct.2023;35.371-374","url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 9 Thyroid NodulesPreoperative Molecular Profiling of Bethesda V and Bethesda VI Thyroid Nodules May Inform Initial Surgical Approach and the Intensity of Postoperative SurveillanceJessica Bindra, Matti L. Gild, and Venessa TsangJessica BindraDepartment of Endocrinology, Diabetes, and Metabolism, Department of Endocrinology, Royal North Shore Hospital; Faculty of Medicine and Health, University of Sydney; Cancer Genetics and Diagnostic Laboratory, Kolling Institute; New South Wales, AustraliaSearch for more papers by this author, Matti L. GildDepartment of Endocrinology, Diabetes, and Metabolism, Department of Endocrinology, Royal North Shore Hospital; Faculty of Medicine and Health, University of Sydney; Cancer Genetics and Diagnostic Laboratory, Kolling Institute; New South Wales, AustraliaSearch for more papers by this author, and Venessa TsangDepartment of Endocrinology, Diabetes, and Metabolism, Department of Endocrinology, Royal North Shore Hospital; Faculty of Medicine and Health, University of Sydney; Cancer Genetics and Diagnostic Laboratory, Kolling Institute; New South Wales, AustraliaSearch for more papers by this authorPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.371-374AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Jessica Bindra, Matti L. Gild, and Venessa Tsang.Preoperative Molecular Profiling of Bethesda V and Bethesda VI Thyroid Nodules May Inform Initial Surgical Approach and the Intensity of Postoperative Surveillance.Clinical Thyroidology®.Sep 2023.371-374.http://doi.org/10.1089/ct.2023;35.371-374Published in Volume: 35 Issue 9: September 13, 2023PDF download","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"132 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135298069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Comparison of Diffuse Sclerosing with Classic and Tall-Cell Papillary Thyroid Carcinomas 弥漫性硬化与典型甲状腺乳头状癌和高细胞甲状腺乳头状癌的比较

Clinical thyroidology Pub Date : 2023-09-01 DOI: 10.1089/ct.2023;35.381-383

Sara Ahmadi

引用次数: 0